Books on the topic 'Pharmaceutical biotechnology – Patents'

1943-, Ludwig S. Peter, and Practising Law Institute, eds. Biotechnology & pharmaceutical law, 2004: Patents & business strategies. New York, NY: Practising Law Institute, 2004.

Barr, David K., and Daniel L. Reisner. Developments in pharmaceutical and biotech patent law 2013. New York, N.Y: Practising Law Institute, 2013.

Lalitha, N. Patents and biopharmaceuticals in India: Emerging issues. Ahmedabad: Gujarat Institute of Development Research, 2006.

Barr, David K., and Daniel L. Reisner. Developments in pharmaceutical and biotech patent law 2010. New York, N.Y: Practising Law Institute, 2010.

Barr, David K., and Daniel L. Reisner. Developments in pharmaceutical and biotech patent law 2012. New York, N.Y: Practising Law Institute, 2012.

Barr, David K., and Daniel L. Reisner. Developments in pharmaceutical and biotech patent law 2009. New York, N.Y: Practising Law Institute, 2009.

Patent law in biotechnology, chemicals & pharmaceuticals. 2nd ed. New York, N.Y., USA: Stockton, 1994.

Wegner, Harold C. Patent law in biotechnology, chemicals & pharmaceuticals. New York, N.Y., USA: Stockton Press, 1992.

ANDA litigation: Strategies & tactics for pharmaceutical patent litigators. Chicago: American Bar Association, 2012.

Angelmar, Reinhard. "Patents and the European biotechnology lag: A study of large European pharmaceutical firms". Fontainbleau: INSEAD, 1986.

Imitation to innovation in China: The role of patents in biotechnology and pharmaceutical industries. Cheltenham, UK: Edward Elgar, 2010.

Follow-on biologics: Hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Tenth Congress, first session, on examining Food and Drug Administration follow-on biologics, generally referred to as a biotechnology-derived protein drug (or biologic) that is comparable to a novel, previously approved biologic and that is approved with less supporting data than the innovator biologic, March 8, 2007. Washington: U.S. G.P.O., 2008.

Emerging health care issues: Follow-on biologic drug competition : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Eleventh Congress, first session, June 11, 2009. Washington: U.S. G.P.O., 2012.

W, Grubb Philip, ed. Patents for chemicals, pharmaceuticals, and biotechnology: Fundamentals of global law, practice, and strategy. Oxford: Clarendon Press, 1999.

Patents for chemicals, pharmaceuticals, and biotechnology: Fundamentals of global law, practice, and strategy. 4th ed. Oxford: Oxford University Press, 2004.

Biologics and biosimilars: Balancing incentives for innovation : hearing before the Subcommittee on Courts and Competition Policy of the Committee on the Judiciary, House of Representatives, One Hundred Eleventh Congress, first session, July 14, 2009. Washington: U.S. G.P.O., 2010.

Voet, Martin A. The generic challenge: Understanding patents, FDA & pharmaceutical life-cycle management. 2nd ed. Boca Raton: BrownWalker Press, 2008.

Wörner, Beate. Von Gen-Piraten und Patenten. Frankfurt a. M: Brandes & Apsel, 2000.

Competition law and patents: A follow-on innovation perspective in the biopharmaceutical industry. Cheltenham, UK: Edward Elgar, 2008.

American Bar Association. Section of Intellectual Property Law, ed. Pre-ANDA litigation: Strategies and tactics for developing a drug product and patent portfolio. Chicago, Illinois: ABA Section of Intellectual Property Law, 2014.

Quarterman-Noah, Belinda G. International pharmaceutical and biotechnology law: Medicine, food and nutrition have taken center stage as mechanisms for improving the health of human beings. United States: Borders, 2005.

Quarterman-Noah, Belinda G. International pharmaceutical and biotechnology law: Medicine, food and nutrition have taken center stage as mechanisms for improving the health of human beings. United States: Borders, 2005.

Quarterman-Noah, Belinda G. International pharmaceutical and biotechnology law: Medicine, food and nutrition have taken center stage as mechanisms for improving the health of human beings. United States: Borders, 2005.

Gutiérrez, Daniel J. Follow-on biologics: Background and issues. New York: Nova Science, 2011.

Wegner, Harold C. Patent Law in Biotechnology, Chemicals & Pharmaceuticals. London: Palgrave Macmillan UK, 1992. http://dx.doi.org/10.1007/978-1-349-21958-2.

Grubb, Philip W. Patents for chemicals, pharmaceuticals, and biotechnology: Fundamentals of global law, practice, and strategy. 5th ed. Oxford: Oxford University Press, 2010.

R, Thomsen Peter, ed. Patents for chemicals, pharmaceuticals, and biotechnology: Fundamentals of global law, practice, and strategy. 5th ed. Oxford: Oxford University Press, 2010.

Pharmaceutical, biotechnology, and chemical inventions: World protection and exploitation. Oxford: Oxford University Press, 2011.

Association, European Generic Medicines. EGA handbook on biosimilar medicines. Brussels: European Generic Medicines Association, 2008.

Niazi, Sarfaraz. Handbook of biogeneric therapeutic proteins: Regulatory, manufacturing, testing, and patent issues. Boca Raton: Taylor & Francis, 2006.

service), Palgrave Connect (Online, ed. Impact of TRIPS in India: An access to medicines perspective. Basingstoke, Hampshire: Palgrave Macmillan, 2010.

United States. Congress. Senate. Committee on the Judiciary. The law of biologic medicine: Hearing before the Committee on the Judiciary, United States Senate, One Hundred Eighth Congress, second session, June 23, 2004. Washington: U.S. G.P.O., 2004.

Regulating bioprospecting: Institutions for drug research, access, and benefit-sharing. Tokyo: United Nations University Press, 2005.

Swain, Beverley J. Biotechnology Patents in the Pharmaceutical Industry. Urch Publishing Ltd, 1998.

Biotechnology and Pharmaceutical Patents: Law and Practice. Aspen Publishers, Inc., 2007.

Patents for Chemicals, Pharmaceuticals and Biotechnology. Oxford University Press, 2016.

Esq, Dr Belinda G., and Quarterman-Noah. International Pharmaceutical and Biotechnology Law. Borders Personal Publishing, 2004.

Li, Yahong. Imitation to Innovation in China: The Role of Patents in Biotechnology and Pharmaceutical Industries. Elgar Publishing Limited, Edward, 2010.

Grubb, Philip W. Patents for Chemicals, Pharmaceuticals and Biotechnology: Fundamentals of Global Law, Practice and Strategy. Oxford University Press, USA, 2005.

Grubb, Philip W., Peter R. Thomsen, Tom Hoxie, and Gordon Wright. Patents for Chemicals, Pharmaceuticals, and Biotechnology. Oxford University Press, 2016. http://dx.doi.org/10.1093/oso/9780199684731.001.0001.

Research and Development of Vaccines and Pharmaceuticals from Biotechnology: A Guide to Effective Project Management, Patenting and Product Registra. John Wiley & Sons, 1994.

Patents As Protection Of Traditional Medical Knowledge A Law And Economics Analysis. Intersentia, 2012.

Section of Intellectual Property Law Staff American Bar Association and Kenneth L. Dorsney. Pre-ANDA Litigation: Strategies and Tactics for Developing a Drug Product and Patent Portfolio. American Bar Association, 2022.

Intellectual Property Issues Therapeutics Vaccines And Molecular Diagnostics. Springer, 2012.

Mehta, Shreefal S. Commercializing Successful Biomedical Technologies: Basic Principles for the Development of Drugs, Diagnostics and Devices. Cambridge University Press, 2008.

Commercializing Successful Biomedical Technologies. Cambridge University Press, 2008.

Mehta, Shreefal S. Commercializing Successful Biomedical Technologies: Basic Principles for the Development of Drugs, Diagnostics and Devices. Cambridge University Press, 2008.

Mehta, Shreefal S. Commercializing Successful Biomedical Technologies. Cambridge University Press, 2022.

Commercializing Successful Biomedical Technologies: Basic Principles for the Development of Drugs, Diagnostics and Devices. Cambridge University Press, 2008.

Mehta, Shreefal S. Commercializing Successful Biomedical Technologies: Basic Principles for the Development of Drugs, Diagnostics and Devices. Cambridge University Press, 2008.